Wiep Klaas Smits (ExpBac/CMAT)

Wiep Klaas Smits (ExpBac/CMAT)

@smitslab.bsky.social

Assoc. prof. at LUMC/@unileiden. Cdiff, DNA replication, AMR, microbiome, anaerobes. Clostpath Steering committee. Education officer ESGCD. Previously: @unigroningen and @mitofficial. https://sites.google.com/view/expbac-lumc/homepage

1.4K followers682 following440 posts

Wiep Klaas Smits (ExpBac/CMAT) reposted

Finding new covalent antibiotics usually hits two major walls: the time-consuming synthesis of tailored libraries and the challenge of target identification after phenotypic screening. Storm van der Voort addressed both bottlenecks in one comprehensive workflow. (1/8) doi.org/10.26434/che...

Wiep Klaas Smits (ExpBac/CMAT) reposted

Pangenomes. Yersinia. This is just heaven for me. Awesome paper!!! Would like a wee bit more info on how the plasmid was ID’d from the methods used. But my god this is a read!

fseersholm.bsky.social@fseersholm.bsky.social

Do you like riddles(and molecular biology)? Maybe you can help me solve this one. We’ve found a short piece of DNA (a plasmid) present in almost all plague samples from the Second Plague Pandemic (1338-1840), but absent in all earlier or later plague cases. www.biorxiv.org/content/10.6...

Wiep Klaas Smits (ExpBac/CMAT) reposted

Wiep Klaas Smits (ExpBac/CMAT) reposted

Phases of Clostridioides difficile Infection (CDI) in the United States: The History and Epidemiology of CDI From 1935 to Present academic.oup.com/cid/article-... "It may behoove us to prepare for a different kind of CDI: community-based and insidious rather than hospital-predominant and explosive"

academic.oup.comThe Phases of Clostridioides difficile Infection (CDI) in the United States: The History and Epidemiology of CDI From 1935 to PresentThis review contextualizes Clostridioides difficile infection (CDI) as a phased epidemic. Following a slow emergence and a rapid acceleration driven by hyp

An endolysin-expressing probiotic attenuates Clostridioides difficile infection in germ-free and dysbiotic microbiota-associated mice www.biorxiv.org/content/10.6...

biorxiv.orgAn endolysin-expressing probiotic attenuates Clostridioides difficile infection in germ-free and dysbiotic microbiota-associated miceDisruption of the intestinal microbiota increases susceptibility to Clostridioides difficile infection (CDI), creating an opportunity for prophylactic interventions before symptomatic disease develops. We investigated whether Escherichia coli Nissle 1917 (EcN) engineered to express the bacteriophage-derived endolysin CD27L could enhance pathogen inhibition and attenuate CDI. Using a plasmid-cured EcN chassis and pMUT2-derived vectors, we generated strains expressing CD27L under constitutive or anaerobically regulated promoter control. The constitutive strain, BioEcN1, reduced viable C. difficile recovery relative to parental EcN and was selected for animal studies. BioEcN1 remained recoverable from monoassociated mice without in vivo antibiotic selection, with similar recovery on selective and nonselective media supporting construct retention. Prophylactic administration reduced clinical disease, body-weight loss, and intestinal histopathological injury in germ-free mice. Observed survival was 100% in BioEcN1-treated challenged mice versus 50% in untreated challenged mice during the monitored period. Protection was accompanied by lower fecal and cecal pathogen burdens. In mice harboring a human-derived dysbiotic microbiota, prophylactic BioEcN1 also reduced clinical and stool-consistency scores, with lower early fecal pathogen recovery and less colon shortening. These findings establish preclinical proof of concept for prophylactic administration of an endolysin-expressing probiotic to attenuate CDI. ### Competing Interest Statement The authors have declared no competing interest.

Wiep Klaas Smits (ExpBac/CMAT) reposted

Wiep Klaas Smits (ExpBac/CMAT) reposted

"Our findings underscore that infectious disease spillover and emergence are multi-causal, and that no one-size-fits-all strategy can prevent #epidemics and #pandemics." So what can we do, then? See suggestions in this interesting (but sobering) read #IDSky

Colin Carlson@colincarlson.bsky.social

If you missed it last week, we published the largest ever study on emerging infectious diseases. Not really in vogue right now, but the next pandemic will come sooner than you think. Key lessons: nature-based solutions where you can, health system strengthening always. www.nature.com/articles/s41...

Wiep Klaas Smits (ExpBac/CMAT) reposted

It is happening, and registration is open for the EMBO Workshop: Bacterial and archaeal cell division: diverse mechanisms and models. 20–23 April 2027 | Barga, Italy. Come and join us @awehenkel.bsky.social, @seamusholden.bsky.social, @s-lab.bsky.social ! Deadline: Jan 6, 2027. #Bacdiv27

EMBO@embo.org

Sign up now for the EMBO Workshop "Bacterial and archaeal #CellDivision: Diverse mechanisms and models" in Barga (Lucca), Italy, 20–23 April 2027. Deadline: 6 January 2027 https://meetings.embo.org/event/27-cell-division #EMBObacDiv27 #genetics #biochemistry #StructuralBiology #EMBOevents 🧪

It's a wrap! #ICDS2026 has come to an end. As usual, flawless execution, great crowd. There will be another ICDS in two years - but not organised by Maja Rupnik anymore. Lots of respect and appreciation for what she has done over the past decades for the #cdiff community.

Wiep Klaas Smits (ExpBac/CMAT) reposted

Wiep Klaas Smits (ExpBac/CMAT) reposted

Thrilled to share this insightful work of Asher King @subtisilly.bsky.social and Pilar Horigian @pilarhorigian.bsky.social! #ProudPI #MicroSky #AMR #SubtiWiki In this work, we reveal the *magic* behind the protective effects of magnesium in Bacillus subtilis. Read Asher's 🧵 below for more details.